Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaping Chu

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 22, 2002
Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degenerationStephane Palfi, Liza Leventhal, Yaping Chu, et al.
Acta Neuropathologica|May 21, 2017
Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteinsWilliam P Flavin, Luc Bousset, Zachary C Green, et al.
Acta Neuropathologica Communications|March 24, 2025
Proximity proteomics reveals unique and shared pathological features between multiple system atrophy and Parkinson's diseaseSolji G Choi, Tyler R Tittle, Raj R Barot, et al.
Brain : a Journal of Neurology|July 26, 2013
Disease duration and the integrity of the nigrostriatal system in Parkinson's diseaseJeffrey H Kordower, C Warren Olanow, Hemraj B Dodiya, et al.
Annals of Neurology|July 25, 2006
Proteasome inhibition and Parkinson's disease modelingJordi Bové, Chun Zhou, Vernice Jackson-Lewis, et al.
Neurobiology of Disease|January 27, 2007
Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonismTimothy J Collier, Jack Lipton, Brian F Daley, et al.
Brain Research|March 21, 2007
Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's diseaseDeanna M Marchionini, Elin Lehrmann, Yaping Chu, et al.
Annals of Neurology|July 25, 2006
Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeysJeffrey H Kordower, Nicholas M Kanaan, Yaping Chu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 16, 2011
Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brainsRaymond T Bartus, Christopher D Herzog, Yaping Chu, et al.
Human Molecular Genetics|July 1, 2015
Analysis of YFP(J16)-R6/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington's diseaseRodolfo G Gatto, Yaping Chu, Allen Q Ye, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 22, 2002
Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degenerationStephane Palfi, Liza Leventhal, Yaping Chu, et al.
Acta Neuropathologica|May 21, 2017
Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteinsWilliam P Flavin, Luc Bousset, Zachary C Green, et al.
Acta Neuropathologica Communications|March 24, 2025
Proximity proteomics reveals unique and shared pathological features between multiple system atrophy and Parkinson's diseaseSolji G Choi, Tyler R Tittle, Raj R Barot, et al.
Brain : a Journal of Neurology|July 26, 2013
Disease duration and the integrity of the nigrostriatal system in Parkinson's diseaseJeffrey H Kordower, C Warren Olanow, Hemraj B Dodiya, et al.
Annals of Neurology|July 25, 2006
Proteasome inhibition and Parkinson's disease modelingJordi Bové, Chun Zhou, Vernice Jackson-Lewis, et al.
Neurobiology of Disease|January 27, 2007
Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonismTimothy J Collier, Jack Lipton, Brian F Daley, et al.
Brain Research|March 21, 2007
Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's diseaseDeanna M Marchionini, Elin Lehrmann, Yaping Chu, et al.
Annals of Neurology|July 25, 2006
Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeysJeffrey H Kordower, Nicholas M Kanaan, Yaping Chu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 16, 2011
Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brainsRaymond T Bartus, Christopher D Herzog, Yaping Chu, et al.
Human Molecular Genetics|July 1, 2015
Analysis of YFP(J16)-R6/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington's diseaseRodolfo G Gatto, Yaping Chu, Allen Q Ye, et al.
Pageof 7